← FDA Drug Approvals (Drugs@FDA)

HYMPAVZI

BLA · Biologics License Application · Sponsor: PFIZER INC · Approved 2024-10-11

Drug application

FDA Application #
BLA761369
Application type
Biologics License Application
Brand name
HYMPAVZI
Generic name
MARSTACIMAB-HNCQ
Active ingredients
MARSTACIMAB-HNCQ
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
Marketing status
Prescription
Sponsor
PFIZER INC
Manufacturer
Pfizer Laboratories Div Pfizer Inc
First approval
2024-10-11

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown